publication date: Dec. 21, 2010

In this issue: 

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer;

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints;

ODAC Reviews Post-Marketing Studies for Eight Indications;

Georgetown Sponsors Oncology Agent Development Meeting;

Bush Appoints Kripke To President’s Cancer Panel;

Letter to the Editor

(8-page issue).

Download (PDF 224KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.